FDA 483 - Kenneth N. Sokolski, M.D. - March 08, 2013
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Kenneth N. Sokolski, M.D. (Clinical Innovations, Inc.) in Costa Mesa, CA, revealed significant deficiencies in the conduct of clinical investigations. The firm failed to adhere to signed investigator statements and investigational plans, leading to numerous protocol deviations across multiple studies. Additionally, the inspection found a failure to maintain accurate case histories, with multiple discrepancies between source documents and electronic case report forms.
ID · d5cad906-09c4-40b5-888c-ccbfe0eb7eac